Drug distributors strike 1st opioid settlement with Native American tribe for $75 million
Reuters
Published Sep 28, 2021 11:49AM ET
Updated Sep 28, 2021 02:56PM ET
By Nate Raymond
(Reuters) -The three largest U.S. drug distributors will pay more than $75 million to resolve claims they fueled an opioid epidemic in the Cherokee Nation's territory in Oklahoma, marking the first settlement with a tribal government in the litigation over the U.S. addiction crisis.
Cherokee Nation Principal Chief Chuck Hoskin on Tuesday said the settlement, which will be paid over 6-1/2 years, would "enable us to increase our investments in mental health treatment facilities and other programs to help our people recover."
The deal announced by the Cherokee Nation came after distributors McKesson Corp (NYSE:MCK), AmerisourceBergen (NYSE:ABC) Corp and Cardinal Health Inc (NYSE:CAH), along with the drugmaker Johnson & Johnson (NYSE:JNJ), agreed to pay up to $26 billion to resolve similar claims by states and local governments.
That settlement did not cover any of the country's Native American tribes. The three distributors are in talks to resolve those cases, and other companies continue to face similar lawsuits.
Drugmakers Teva Pharmaceutical Industries (NYSE:TEVA) Ltd and Endo International (NASDAQ:ENDP) Plc on Tuesday separately said they agreed to pay $15 million and $7.5 million, respectively, to resolve claims they contributed to the opioid epidemic in Louisiana. Teva will also donate $3 million worth of medications.
The distributors in a statement called the deal "an important step toward reaching a broader settlement with all federally recognized Native American tribes across the country." The companies deny wrongdoing.
The Cherokee Nation became the first Native American tribe to sue drug distributors and pharmacy operators in 2017. The sovereign Cherokee Nation has more than 390,000 citizens.
It accused the distributors of flooding its territory with millions of prescription opioid pills, an oversupply of addictive painkillers that resulted in abuse and overdose deaths that disproportionately affected Native Americans.
More than 3,300 similar lawsuits have been filed by states, counties, cities and tribal governments. Nearly 500,000 people died due to opioid overdoses in the United States from 1999 to 2019, according to the U.S. Centers for Disease Control and Prevention.
Get The News You Want
The Cherokee Nation, represented by the law firms Boies Schiller Flexner, Fields PLLC, and Whitten Burrage, also sued pharmacy operators CVS Health (NYSE:CVS), Walgreens Boots Alliance (NASDAQ:WBA) Inc and Walmart (NYSE:WMT) Inc. They deny wrongdoing.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.